StockData

Geospace Technologies vs MIND Technology

GEOS and MIND side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How GEOS and MIND compare

Geospace Technologies is the larger company, worth 1.6 times as much as MIND Technology ($46.0M against $28.6M).

Geospace Technologies grew revenue faster over the last twelve months (−20.5% versus −28.5% for MIND Technology).

MIND Technology keeps more of each dollar of sales as profit, with a net margin of −6.8% compared with −43.1% at Geospace Technologies.

MIND Technology scores higher on the StockData Score (10 against 7 for Geospace Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricGEOSMIND
Size and price
Market cap$46.0M$28.6M
Share price$3.56$3.15
Change, 1 year−87.2%−77.1%
Change, 5 years−59.8%−78.0%
Beta (5Y)0.560.87
Employees519157
StockData Score
Total score710 (better)
Valuation score33
Growth score01 (better)
Performance score01 (better)
Health score45 (better)
Dividend score00
Valuation
P/S0.5× (better)0.8×
P/B0.5× (better)0.7×
FCF yield−80.3%−13.5% (better)
Fair value$16.21$8.02
Margin of safety78.1% (better)60.7%
Growth
Revenue growth (TTM)−20.5% (better)−28.5%
Revenue growth, 5Y average4.8%14.1% (better)
Net income growth (TTM)–−155%
EPS growth (TTM)–−108%
Profitability
Gross margin8.0%42.2% (better)
Operating margin−44.7%−2.7% (better)
Net margin−43.1%−6.8% (better)
FCF margin−40.2%−11.1% (better)
Return on equity−34.4%−6.8% (better)
Return on invested capital−32.1%−3.2% (better)
Financial health
Debt / equity0.000.00
Interest coverage−539.6×–
Current ratio2.446.92 (better)
Altman Z-score1.15 (better)1.03
Piotroski F-score26 (better)
Dividends and buybacks
Buyback yield0.00%–
Shareholder yield0.00%0.00%
Ownership
Held by institutions40.1%14.3%
Held by insiders4.4%1.5%
Short interest, % of float2.4%2.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.